Keywords: neurosearch, takes, back, tesofensine, after, boeh, ing

NeuroSearch takes back Tesofensine after Boeh Ing abandons it

Article | 30 January 2006

Danish drugmaker NeuroSearch will continue the development of tesofensine (NS2330) after German drug major Boehringer Ingelheim has retunerd rights to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Boehringer Ingelheim

Go to company listing